Mekonnen, Y.
Wolde, E.
Hagos, T.
Yared, K.
Bekele, A.
Mehari, Z.
Abebe, S.
Tadesse, Y.
Taye, T.
Asire, G.
Nigatu, T.
Kumar, S.
Girma, S.
Article History
Received: 7 September 2024
Accepted: 22 April 2025
First Online: 8 May 2025
Declarations
:
: The study obtained informed verbal consent from study participants and this was approved by the ethical board of the Amhara Public Health Institute (APHI). Written consent was not required for this study. The ethical approval number was APHI/RTD/865.All methods of this study were carried out in accordance with the Helsinki Declaration on the ethical principles for medical research involving human subjects []. The study protocol was approved by the Amhara Public Health Institute (APHI) ethical board.The study did not involve gathering sensitive information from the women, and there was no invasive procedure or test of drugs or procedures used in the ENAT intervention. The ENAT intervention simply improved availability and access of point of care testing and infection prevention which are within the Ethiopia national ANC guideline. The services given to the pregnant women were in accordance with the Ethiopia National ANC guideline [].Study data collection teams were specifically instructed on the importance of obtaining informed consent and respecting the voluntary participation of respondents, their privacy, and the confidentiality of the data collected. There was no remuneration to the women who participated in this study. All the information and data were accumulated, organized, stored, analyzed, and retrieved, guaranteeing confidentiality.
: Not applicable.
: The authors declare no competing interests.